⌘K
Loading ticker…
As of 2026-08-21, Pyxis Oncology, Inc. Common Stock (PYXS) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 72. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 15.8%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
PYXS is held by 2 ETFs as of May 2026. Top owner: IBBQ at 0.01% weight, $6K notional.
Held by 6 ETFs · $4M across latest filings · largest weight 0.02% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated May 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PYXS Jan avg: 38.70% median: 21.25% win: 100% σ: 49.76% n: 4 2022-04-12 → 2026-07-31 | PYXS Feb avg: 22.40% median: 23.45% win: 75% σ: 41.35% n: 4 2022-04-12 → 2026-07-31 | PYXS Mar avg: 6.32% median: -9.17% win: 25% σ: 48.71% n: 4 2022-04-12 → 2026-07-31 | PYXS Apr avg: -5.62% median: 4.46% win: 60% σ: 23.42% n: 5 2022-04-12 → 2026-07-31 | PYXS May avg: 1.98% median: 5.88% win: 80% σ: 10.65% n: 5 2022-04-12 → 2026-07-31 | PYXS Jun avg: 4.50% median: -9.09% win: 20% σ: 35.59% n: 5 2022-04-12 → 2026-07-31 | PYXS Jul avg: 4.08% median: 1.82% win: 80% σ: 11.53% n: 5 2022-04-12 → 2026-07-31 | PYXS Aug avg: -1.70% median: -2.79% win: 25% σ: 12.23% n: 4 2022-04-12 → 2026-07-31 (current) | PYXS Sep avg: 9.40% median: -5.94% win: 25% σ: 43.58% n: 4 2022-04-12 → 2026-07-31 | PYXS Oct avg: 9.05% median: -4.04% win: 25% σ: 34.68% n: 4 2022-04-12 → 2026-07-31 | PYXS Nov avg: -6.25% median: -13.63% win: 25% σ: 38.14% n: 4 2022-04-12 → 2026-07-31 | PYXS Dec avg: -23.65% median: -14.99% win: 25% σ: 38.96% n: 4 2022-04-12 → 2026-07-31 |